This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
S

ASCO® 2024 Insights: "FIH Trial of M9140, an Anti-CEACAM5 ADC With Exatecan Payload, in Pts With mCRC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Scott Kopetz
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Scott Kopetz
45 views
June 12, 2024
0 Comments
Login to view comments. Click here to Login

2024 ASCO® Annual Meeting Insights Hub: GI Videos

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Botensilimab + Balstilimab in Microsatell…

Feat. A. Bullock
12:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreat…

Feat. J. Knox
12:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

Feat. C. Eng
View All

Related Content

AUTOPLAY
16:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

Feat. V. Subbiah
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
15:51
Total Health

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Feat. A. Grothey
13:29
Ibrahim Sahin

Treating KRAS-Mutated mCRC

09:25
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including T…

Feat. N. Uboha, K. Spencer, M. Cecchini
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
55:10
University of Colorado Cancer Center

History of Cancer and Its Treatment: What Will It Take to Cure?

Feat. C. Lieu
18:02
Ibrahim Sahin

Treating HER2-Amplified mCRC

06:51
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PanaMa Trial - FU/FA Maintenance Therapy …

Feat. D. Modest
18:23
Ibrahim Sahin

Treating BRAF-Mutated mCRC

11:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase III FIRE-4 Study - Influence of Bas…

Feat. S. Stintzing
15:56
Van Morris

ASCO Updated Guidelines for the Treatment of Metastatic Colorectal C…

Feat. C. Eng
07:16
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "CheckMate-8HW Clinical Implica…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
16:39
UChicago Medicine

Treatment of mCRC After Standard Chemotherapy

Feat. A. Shergill
12:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

Feat. C. Eng
06:26
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "64-Month Follow-Up From CheckMate 142 - 1…

Feat. H. Lenz
15:31
Shivaani Kummar

Clinical Implications of Tumor Agnostic Therapies

18:34
Total Health

Management of Colorectal Liver Metastases

Feat. S. Gholami
05:24
Marc Peeters

Integrating MMR/MSI, RAS, BRAF, and HER2 as Targetable Biomarkers In…

21:24
Fred Hutchinson Cancer Center

Re-Challenge With Systemic Therapy for mCRC

Feat. R. Hsieh